New Paradigms Brewing In Atrial Fibrillation Ablation
Executive Summary
Groundbreaking new mapping technologies could shift the future direction of the $2.5 billion AF ablation market, as evidenced by presentations at this year’s HRS and EUROPACE meetings; with some compelling clinical data now on the books, the electrophysiologists who perform AF ablation are taking notice, as are investors and strategics operating in this space. Emerging companies at the heart of this shift include Topera Medical, CardioInsight Technologies, and Acutus Medical.
You may also be interested in...
AF Ablation Procedures Driving CRM Market Expansion
Cardiac rhythm management device sales in the US are projected to grow at a compound annual rate of 2.9%, increasing to an estimated $8.2 billion in the year 2019. Two of the fastest growing sectors of the market, electrophysiology and ablation devices, will be driven by a 10% to 20% growth in the number of patients treated for atrial fibrillation.
St. Jude Medical Expands Presence In Electrophysiology Market With New Advanced Ablation Catheter
St. Jude Medical expands its presence in the electrophysiology market after gaining European regulatory approval of FlexAbility, the company’s next-generation flexible ablation catheter, and expects to receive US FDA 510(k) clearance for the device by year-end.
Abbott Enters Electrophysiology Fray With Topera, ACT Deals
The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.